CL121 is a Glutaminyl Cyclase inhibitor with an IC50 of 0.07 µM against human sQC and an IC50 of 0.54 µM against human gQC. CL121 reduces the level of pyroglutamate (pE)-modified CD47 on the surface of cancer cells. CL121 exhibits anti-tumor activity against triple-negative breast cancer[1].
Molekulargewicht:
351.40
Formel:
C20H21N3O3
Target-Kategorie:
Amyloid-beta,CD47
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
